The influence of ferucarbotran on the chondrogenesis of human mesenchymal stem cells

被引:61
作者
Henning, Tobias D. [1 ,2 ]
Sutton, Elizabeth J. [1 ,3 ]
Kim, Anne [4 ]
Golovko, Daniel [1 ]
Horvai, Andrew [5 ]
Ackerman, Larry [6 ]
Sennino, Barbara [6 ]
McDonald, Donald [6 ]
Lotz, Jeffrey [4 ]
Daldrup-Link, Heike E. [1 ]
机构
[1] Univ Calif San Francisco, Med Ctr, Dept Radiol, San Francisco, CA 94143 USA
[2] Tech Univ Munich, Dept Radiol, Munich, Germany
[3] Boston Univ, Dept Med, Boston, MA 02215 USA
[4] Univ Calif San Francisco, Dept Orthoped Surg, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Ctr Canc, Dept Pathol, San Francisco, CA 94143 USA
[6] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA
关键词
MR imaging; molecular imaging; stem cells; cartilage; tissue engineering; iron oxides; cell tracking; SUPERPARAMAGNETIC IRON-OXIDE; MR CONTRAST AGENTS; IN-VIVO; MAGNETIC-RESONANCE; DIFFERENTIATION; FERUMOXIDES; CARTILAGE; TRACKING; RAT; NANOPARTICLES;
D O I
10.1002/cmmi.276
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
For in vivo applications of magnetically labeled stem cells, biological effects of the labeling procedure have to be precluded. This study evaluates the effect of different ferucarbotran cell labeling protocols on chondrogenic differentiation of human mesenchymal stem cells (hMSC) as well as their implications for MR imaging. hMSC were labeled with ferucarbotran using various protocols: cells were labeled with 100 mu g Fe/ml for 4 and 18 h and additional samples were cultured for 6 or 12 days after the 18 h labeling. Supplementary samples were labeled by transfection with protamine sulfate. Iron uptake was quantified by ICP-spectrometry and labeled cells were investigated by transmission electron microscopy and by immunostaining for ferucarbotran. The differentiation potential of labeled cells was compared with unlabeled controls by staining with Alcian blue and Hematoxylin and Eosin, then quantified by measurements of glucosaminoglycans (GAG). Contrast agent effect at 3 T was investigated on days 1 and 14 of chondrogenic differentiation by measuring signal-to-noise ratios on T-2-SE and T-2*-GE sequences. Iron uptake was significant for all labeling protocols (p < 0.05). The uptake was highest after transfection with protamine sulfate (25.65 +/- 3.96 pg/cell) and lowest at an incubation time of 4 h without transfection (3.21 +/- 0.21 pg/cell). While chondrogenic differentiation was decreased using all labeling protocols, the decrease in GAG synthesis was not significant after labeling for 4 h without transfection. After labeling by simple incubation, chondrogenesis was found to be dose-dependent. MR imaging showed markedly lower SNR values of all labeled cells compared with the unlabeled controls. This contrast agent effect persisted for 14 days and the duration of differentiation. Magnetic labeling of hMSC with ferucarbotran inhibits chondrogenesis in a dose-dependent manner when using simple incubation techniques. When decreasing the incubation time to 4 h, inhibition of chondrogenesis was not significant. Copyright (C) 2009 John Wiley & Sons, Ltd.
引用
收藏
页码:165 / 173
页数:9
相关论文
共 48 条
  • [1] Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells
    Arbab, AS
    Yocum, GT
    Rad, AM
    Khakoo, AY
    Fellowes, V
    Read, EJ
    Frank, JA
    [J]. NMR IN BIOMEDICINE, 2005, 18 (08) : 553 - 559
  • [2] Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI
    Arbab, AS
    Yocum, GT
    Kalish, H
    Jordan, EK
    Anderson, SA
    Khakoo, AY
    Read, EJ
    Frank, JA
    [J]. BLOOD, 2004, 104 (04) : 1217 - 1223
  • [3] In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver
    Bos, C
    Delmas, Y
    Desmoulière, A
    Solanilla, A
    Hauger, O
    Grosset, C
    Dubus, I
    Ivanovic, Z
    Rosenbaum, J
    Charbord, P
    Combe, C
    Bulte, JWM
    Moonen, CTW
    Ripoche, J
    Grenier, N
    [J]. RADIOLOGY, 2004, 233 (03) : 781 - 789
  • [4] Magnetic labeling of non-phagocytic adherent cells with iron oxide nanoparticles: a comprehensive study
    Boutry, Sebastien
    Brunin, Stephanie
    Mahieu, Isabelle
    Laurent, Sophie
    Elst, Luce Vander
    Muller, Robert N.
    [J]. CONTRAST MEDIA & MOLECULAR IMAGING, 2008, 3 (06) : 223 - 232
  • [5] Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling with ferumoxides
    Bulte, JWM
    Kraitchman, DL
    Mackay, AM
    Pittenger, MF
    [J]. BLOOD, 2004, 104 (10) : 3410 - 3412
  • [6] Centeno CJ, 2008, PAIN PHYSICIAN, V11, P343
  • [7] The guidance of human mesenchymal stem cell differentiation in vitro by controlled modifications to the cell substrate
    Curran, Judith M.
    Chen, Rui
    Hunt, John A.
    [J]. BIOMATERIALS, 2006, 27 (27) : 4783 - 4793
  • [8] In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging
    Daldrup-Link, HE
    Meier, R
    Rudelius, M
    Piontek, G
    Piert, M
    Metz, S
    Settles, M
    Uherek, C
    Wels, W
    Schlegel, J
    Rummeny, EJ
    [J]. EUROPEAN RADIOLOGY, 2005, 15 (01) : 4 - 13
  • [9] Targeting of hematopoietic progenitor cells with MR contrast agents
    Daldrup-Link, HE
    Rudelius, M
    Oostendorp, RAJ
    Settles, M
    Piontek, G
    Metz, S
    Rosenbrock, H
    Keller, U
    Heinzmann, U
    Rummeny, EJ
    Schlegel, J
    Link, TM
    [J]. RADIOLOGY, 2003, 228 (03) : 760 - 767
  • [10] Mesenchymal stem cells: Biology and potential clinical uses
    Deans, RJ
    Moseley, AB
    [J]. EXPERIMENTAL HEMATOLOGY, 2000, 28 (08) : 875 - 884